Delivery Order SPE2DU25D4211-SPE2DU26FB964
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $25,466.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 2, 2026, with an ultimate completion date of January 5, 2026. This unset-aside, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $14,257.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, with completion expected by October 21, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order is to be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $40,413.57 to AmerisourceBergen Drug Corp on January 5, 2026, with an ultimate completion date of January 6, 2026. This firm fixed price delivery order, issued under contract number 4570403734, requires performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made competitively with no set-aside designation, reflecting the contractor's established capability to...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,411.07 to AmerisourceBergen Drug Corp on December 18, 2025, with an ultimate completion date of December 19, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor and represents a task order issued under a larger contract vehicle. The work is to be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $327,131.28 to AmerisourceBergen Drug Corp on December 30, 2025, with completion expected by December 31, 2025. This firm fixed-price delivery order, issued without set-aside provisions, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $14,793.00 delivery order (Contract No. 4570130885) to AmerisourceBergen Drug Corp on December 1, 2025, with a completion date of December 2, 2025. This firm fixed price, non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order will be performed at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.58 to AmerisourceBergen Drug Corp on January 5, 2026, under its Pharmaceutical Delivery Order contract. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by January 6, 2026, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract action under the company's...
- The Defense Logistics Agency awarded a $1,459.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This non-set-aside competitive award represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at AmerisourceBergen's Corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,822.30 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies on December 10, 2025, with completion expected by December 11, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,092.31 to AmerisourceBergen Drug Corp on May 13, 2025, with completion targeted for May 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement supporting federal defense healthcare requirements. The work will be performed at AmerisourceBergen's Corporate Office location in...
- SPE2DU25D4211Indefinite Delivery Contract
- SPE2DU25D4211-SPE2DU26FB964Delivery Order
The Defense Logistics Agency (DLA) awarded a $21,110.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, with an ultimate completion date of the same day. This non-competitive delivery order, issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA, tasks the pharmaceutical distributor with supplying pharmaceutical products and medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a small transaction within AmerisourceBergen's substantial $999,999,999.00 prime contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's role as a major pharmaceutical distributor provides the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with access to a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The delivery order reflects the company's ongoing capability to fulfill federal medical procurement requirements through its competitive positioning within DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.1k | 1/4/26 |